Alexandria Co. For Pharmaceuticals & Chemical Industries (EGX: AXPH)
Egypt
· Delayed Price · Currency is EGP 303.32
+8.20 (2.78%)
At close: Dec 2, 2024
AXPH Revenue
In the fiscal year ending June 30, 2024, Alexandria Co. For Pharmaceuticals & Chemical Industries had annual revenue of 1.77B EGP with 19.12% growth. Alexandria Co. For Pharmaceuticals & Chemical Industries had revenue of 261.99M in the quarter ending June 30, 2024, a decrease of -30.20%.
Revenue
1.77B
Revenue Growth
+22.13%
P/S Ratio
0.85
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.50B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 1.77B | 283.76M | 19.12% |
| Jun 30, 2023 | 1.48B | 384.31M | 34.94% |
| Jun 30, 2022 | 1.10B | -4.24M | -0.38% |
| Jun 30, 2021 | 1.10B | 79.44M | 7.75% |
| Jun 30, 2020 | 1.02B | 195.78M | 23.61% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition